US$ 27.29
fda warns against compounded semaglutide alerts health care providers, compounders and patients of dosing errors associated with injectable products FDA Warns About Compounded Versions
Description
Madsbad et al

It might not look like there is enough medication in your vial, but rest assured that there is
(1998) 275:C67583

This varies considerably by program

With a lower list price, the rebate tradeoffs tied to those strategies may be smaller, which may change the cost-benefit balance for some plan sponsors and open the door to additional strategies